Targeting Bcl-xL enhances the cytotoxicity of chemotherapeutics

descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 2008 English Publisher:Informa UK LimitedJournal:Cancer Biology & Therapy, volume 7, pages 61-62 (issn: 1538-4047, eissn: 1555-8576,

Copyright policy )

Authors: Shulin, Wang;

doi: 10.4161/cbt.7.1.5571

pmid: 18347425

Targeting Bcl-xL enhances the cytotoxicity of chemotherapeutics

- Summary
- Subjects
- Metrics

Abstract

Commentary to:Synergistic cytotoxicity of Bcl-xL inhibitor, gossypol and chemotherapeutic agents in non-Hodgkin’s lymphoma cellsZhi-Ming Li, Wen-Qi Jiang, Zhen-Yu Zhu, Xiao-Feng Zhu, Jun-Min Zhou, Zong-Chao Liu, Da-Jun Yang and Zhong-Zhen Guan

Related Organizations

State Key Laboratory of Genetic Engineering
China (People's Republic of)
Fudan University
China (People's Republic of)

Keywords

Proto-Oncogene Proteins c-bcl-2, bcl-X Protein, Humans, Antineoplastic Agents, Apoptosis, Drug Synergism

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average